Keith Orford, Chief Medical Officer at Calithera Biosciences, Inc. (CALA), sold 3,021 shares at $6.00 ($18K) on 2019-12-23, disclosed to the SEC on 2019-12-26.
Scheduled sale ($18k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CALA | SELL | 2020-12-18 | $15K | — | Filing → |
| CALA | SELL | 2020-02-24 | $24K | — | Filing → |
| CALA | SELL | 2019-06-19 | $3K | — | Filing → |